Reflection Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.11M Buy
25,421
+14,913
+142% +$690K 0.46% 53
2026
Q2
$448K Buy
+10,508
New +$571K 0.21% 95
2026
Q1
– Sell
-1,725
Closed -$164K – 164
2025
Q4
$164K Buy
+1,725
New +$169K 0.12% 119

Other funds holding BSX

Reflection Asset Management's BSX Position: Q3 2026 in Review

Reflection Asset Management increased its Boston Scientific (BSX) stake by 142% in Q3 2026, buying an estimated $690K and bringing the position to 25,421 shares worth $1.11M. The position accounts for 0.46% of the portfolio, ranked #53.

Reflection Asset Management first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Reflection Asset Management held 25,421 shares of Boston Scientific worth $1.11M as of Q3 2026.
  • Reflection Asset Management bought 14,913 Boston Scientific shares in Q3 2026, an estimated $690K.
  • Boston Scientific made up 0.46% of Reflection Asset Management's portfolio in Q3 2026, its #53 holding.
  • Reflection Asset Management first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Reflection Asset Management's 13F filing for Q3 2026, filed 28 Oct 2026.